The bowel cancer survival rate depends strongly on the stage at diagnosis. People with early bowel cancer generally have a much better outlook than people whose cancer has spread to distant parts of the body.
However, survival statistics describe groups of people. They cannot tell one person exactly what will happen. Your age, general health, tumour features, treatment and response to treatment can all affect your individual prognosis.
Bowel cancer survival at a glance
- Stage 1: around 90% survive for 5 years or more.
- Stage 2: around 85% survive for 5 years or more.
- Stage 3: around 65% survive for 5 years or more.
- Stage 4: around 10% survive for 5 years or more.
Important: these figures apply to people diagnosed with bowel cancer in England between 2016 and 2020 and followed up to 2021. They describe groups of patients, not an individual person’s life expectancy.
What is the bowel cancer survival rate?
Survival statistics show the proportion of people who survive for a specified period after diagnosis. Researchers commonly report 1-year, 5-year and 10-year survival.
For people with bowel cancer in England, Cancer Research UK reports that around 80% survive for at least 1 year and almost 60% survive for at least 5 years.
Almost 55% survive for 10 years or more. However, this 10-year estimate comes from an earlier group of patients diagnosed in England between 2013 and 2017, so you should not treat all three figures as if they came from one identical study population.
The statistics also use net survival. This method estimates survival from cancer after allowing for the fact that some people would have died from other causes.
Bowel cancer survival rate by stage
The cancer stage gives doctors important information about how far the disease has grown or spread. As a result, stage has a major influence on prognosis.
| Stage at diagnosis | 5-year net survival in England | General meaning |
|---|---|---|
| Stage 1 | Around 90% | Cancer remains relatively localised. |
| Stage 2 | Around 85% | Cancer has grown further into or through the bowel wall but has not reached distant organs. |
| Stage 3 | Around 65% | Cancer has reached nearby lymph nodes. |
| Stage 4 | Around 10% | Cancer has spread to another part of the body. |
These figures come from people diagnosed in England between 2016 and 2020. Cancer Research UK notes that equivalent stage-specific statistics are not available as one UK-wide dataset.
Therefore, avoid comparing these figures directly with statistics from another country, another period or a different staging system.
Stage 1 bowel cancer prognosis
Stage 1 bowel cancer has the highest 5-year survival rate among the four main numbered stages. Around 90 in every 100 people survive their cancer for at least five years after diagnosis.
At this stage, the cancer remains localised and has not spread to lymph nodes or distant organs. Surgery can often remove the cancer.
However, individual outcomes still differ. The position of the tumour, pathology results, general health and other factors can influence treatment and prognosis.
Stage 2 bowel cancer prognosis
Around 85 in every 100 people with stage 2 bowel cancer survive for five years or more.
Stage 2 cancer has grown more deeply through the bowel wall, but doctors have not found cancer in nearby lymph nodes or distant organs.
Surgery remains an important treatment. Doctors may also look for higher-risk features when they decide whether additional treatment could help.
Stage 3 bowel cancer prognosis
About 65 in every 100 people with stage 3 bowel cancer survive their cancer for five years or more.
At stage 3, cancer has reached nearby lymph nodes. However, it has not spread to distant organs.
Treatment commonly includes surgery and chemotherapy. Doctors consider the tumour pathology, number of affected lymph nodes, general health and other clinical factors when planning treatment.
NICE recommends specific adjuvant chemotherapy options for stage 3 colon cancer and advises clinicians to consider pathology, performance status, age, other illnesses and personal preferences when choosing treatment.
Stage 4 bowel cancer prognosis
Stage 4 bowel cancer has spread from the colon or rectum to another part of the body. Doctors also call this metastatic bowel cancer.
Around 10 in every 100 people with stage 4 bowel cancer in the England dataset survive for five years or more. However, this broad number hides major differences between patients.
For example, prognosis can differ according to where the cancer has spread, how much disease is present, whether doctors can remove metastases and how the cancer responds to systemic treatment.
Some people with limited metastatic disease can receive surgery or other targeted treatment as part of a specialist plan. Therefore, a population statistic should never replace advice from the oncology team.
Stage 4 needs a separate discussion
Stage 4 disease varies considerably between individuals. Our separate guide explains metastatic bowel cancer, prognosis, treatment and the factors that can affect outlook in more detail.
What does bowel cancer prognosis mean?
Prognosis describes the likely course or outcome of an illness. Doctors may discuss the chance of successful treatment, risk of recurrence or expected survival.
However, a prognosis is an estimate rather than a prediction of exactly what will happen to one person.
Your specialist has access to information that population statistics cannot capture. This includes your scans, pathology, tumour location, molecular test results, treatment response and overall health.
What affects bowel cancer prognosis?
Stage remains one of the strongest factors, but it is not the only one. Doctors consider several features when they assess prognosis.
- Stage: whether the cancer remains localised or has spread.
- Lymph nodes: how many nearby lymph nodes contain cancer cells.
- Tumour grade: how abnormal the cancer cells look under the microscope.
- Tumour location: colon and rectal cancers can behave and respond to treatment differently.
- Molecular features: tests may identify changes such as RAS, BRAF or mismatch-repair status.
- General health: fitness and other medical conditions can influence treatment options.
- Treatment response: cancers do not all respond to treatment in the same way.
A recent scientific review also highlights tumour stage, grade, lymph-node involvement and molecular biomarkers as important prognostic or predictive factors in colorectal cancer.
Does age affect the bowel cancer survival rate?
Age can influence survival statistics, but age alone does not determine an individual’s outcome.
Older people may have other medical conditions or may not tolerate some treatments as easily. In contrast, two people of the same age can have very different levels of fitness and very different cancers.
The England figures above use age-standardised net survival where appropriate. This helps researchers compare groups more fairly.
Can prognosis improve with time?
Yes. Doctors call this conditional survival.
A person’s outlook can change after they have already survived for a period following diagnosis. Cancer Research UK reports that among people in England who survived bowel cancer for at least one year, around 75% survived to five years or more in the relevant dataset.
This statistic describes survival for a further four years after already reaching the one-year point. It does not mean that every person’s risk changes in exactly the same way.
Treatment can influence outlook
Modern bowel cancer treatment may include surgery, chemotherapy, radiotherapy, targeted medicines and immunotherapy. Doctors choose treatment according to the cancer site, stage, tumour biology and the person’s health.
Earlier diagnosis often gives doctors more treatment options. However, treatment for advanced bowel cancer has also become increasingly individualised.
Can exercise affect survival after colon cancer treatment?
New research provides particularly interesting evidence about physical activity after treatment for some people with colon cancer.
The 2025 CHALLENGE phase 3 trial included 889 people who had undergone surgery for colon cancer and completed adjuvant chemotherapy. Researchers compared a structured three-year exercise programme with health-education materials alone.
The structured exercise group had better disease-free survival. Five-year disease-free survival reached 80.3% in the exercise group compared with 73.9% in the health-education group.
The findings also supported improved overall survival. However, the study involved a specific group of patients after surgery and chemotherapy. Therefore, the results do not apply automatically to every person with bowel cancer.
Survival statistics cannot predict one person’s future
This is one of the most important points to understand when reading survival figures.
Statistics look backwards at groups of people who received a diagnosis several years earlier. Treatments also change over time. In addition, an individual person’s cancer can differ biologically from the average cancer represented in a dataset.
For that reason, your consultant or multidisciplinary team can usually give you a more relevant explanation of your outlook than a general online survival percentage.
Early investigation matters
Survival differs markedly by stage, so unexplained bowel symptoms deserve appropriate medical assessment.
Doctors may use FIT, blood tests, colonoscopy, biopsy and scans when they investigate possible bowel cancer.
Read our guide to tests for bowel cancer.
Learn how the FIT stool test works and what the results can mean.
Read what blood tests can and cannot show.
Read about bowel cancer symptoms and warning signs.
Colon hydrotherapy and bowel wellbeing
Colon hydrotherapy does not treat bowel cancer, improve cancer survival or replace screening, diagnostic tests or oncology care.
However, some people choose colon hydrotherapy as a separate bowel-wellbeing treatment after doctors have investigated concerning symptoms and confirmed that the treatment is suitable for them.
At Parkland Natural Health in Holborn, we take a careful and individual approach. Every appointment includes a private consultation and suitability screening. We use a closed-system, gravity-fed method and explain the procedure before treatment begins.
If you have active cancer, unexplained bleeding, recent bowel surgery or ongoing cancer treatment, speak with your oncology or surgical team first. We may also advise you not to proceed when your medical history makes colon hydrotherapy unsuitable.
For suitable clients, the emphasis remains on privacy, comfort and individual bowel wellbeing rather than disease treatment.
Frequently asked questions about bowel cancer survival
What is the 5-year bowel cancer survival rate?
Across all stages, almost 60% of people with bowel cancer in England survive their cancer for five years or more. Survival differs greatly according to stage.
Which stage of bowel cancer has the best prognosis?
Stage 1 has the highest five-year survival among the main numbered stages. Around 90% of people in the England dataset survived for five years or more.
Can stage 4 bowel cancer be treated?
Yes. Doctors can offer several treatments for metastatic bowel cancer. The aim may involve controlling the cancer, reducing symptoms or, in selected situations, treating limited metastatic disease with surgery or other targeted approaches.
Does a 5-year survival rate mean someone only has five years to live?
No. A five-year survival statistic measures how many people survive to at least that point. Many people live considerably longer.
Can doctors predict exactly how long someone will live?
No. Doctors can discuss probabilities and prognostic factors, but they cannot predict an exact survival time for an individual person.
Trusted medical and scientific sources
The figures and medical information on this page draw on current UK guidance, national cancer statistics and peer-reviewed research.
- Cancer Research UK: Survival for bowel cancer
- Cancer Research UK: Stages, types and grades of bowel cancer
- NICE: Colorectal cancer – recommendations
- PubMed: Prognostic and predictive determinants of colorectal cancer
- New England Journal of Medicine: Structured exercise after adjuvant chemotherapy for colon cancer
Medical information notice: This article provides general information about bowel cancer survival and prognosis. Population statistics cannot predict an individual person’s outcome. Please discuss your diagnosis, treatment and prognosis with your oncology or colorectal team.
